HTR5A-AS1
gene geneOn this page
Summary
HTR5A-AS1 (HTR5A antisense RNA 1, HGNC:48956) is a long non-coding RNA gene on chromosome 7q36.2.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48956 |
| Approved symbol | HTR5A-AS1 |
| Name | HTR5A antisense RNA 1 |
| Location | 7q36.2 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000220575 |
| Ensembl biotype | lncRNA |
| Entrez | 100128264 |
| RNAcentral | URS000075D18F — lncRNA, 2714 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 lncRNA
ENST00000395731, ENST00000493904, ENST00000655797, ENST00000671665
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000395731 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001554074 | 155067067 | 155069245 |
| ENSE00003760096 | 155071034 | 155071557 |
Expression profiles
Bgee: expression breadth broad, 47 present calls, max score 80.75.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6629 / max 63.8719, expressed in 79 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 87003 | 0.2039 | 55 |
| 87002 | 0.2030 | 58 |
| 86999 | 0.1508 | 64 |
| 87000 | 0.0617 | 35 |
| 87001 | 0.0434 | 31 |
Top tissues by expression
47 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| superior frontal gyrus | UBERON:0002661 | 80.75 | gold quality |
| cerebellum | UBERON:0002037 | 80.54 | gold quality |
| cerebellar cortex | UBERON:0002129 | 80.43 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 80.35 | gold quality |
| prefrontal cortex | UBERON:0000451 | 78.93 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 78.84 | gold quality |
| primary visual cortex | UBERON:0002436 | 78.00 | gold quality |
| frontal cortex | UBERON:0001870 | 77.63 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 76.78 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 76.70 | gold quality |
| right frontal lobe | UBERON:0002810 | 75.13 | gold quality |
| cerebral cortex | UBERON:0000956 | 74.25 | gold quality |
| nucleus accumbens | UBERON:0001882 | 73.84 | gold quality |
| putamen | UBERON:0001874 | 73.08 | gold quality |
| caudate nucleus | UBERON:0001873 | 72.54 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 72.52 | gold quality |
| brain | UBERON:0000955 | 72.19 | gold quality |
| multicellular organism | UBERON:0000468 | 69.75 | gold quality |
| temporal lobe | UBERON:0001871 | 62.94 | gold quality |
| amygdala | UBERON:0001876 | 62.62 | gold quality |
| Ammon’s horn | UBERON:0001954 | 61.18 | gold quality |
| cortical plate | UBERON:0005343 | 60.54 | gold quality |
| ventricular zone | UBERON:0003053 | 59.93 | gold quality |
| hypothalamus | UBERON:0001898 | 58.97 | gold quality |
| corpus callosum | UBERON:0002336 | 56.84 | gold quality |
| substantia nigra | UBERON:0002038 | 53.56 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 53.31 | gold quality |
| placenta | UBERON:0001987 | 49.64 | gold quality |
| blood | UBERON:0000178 | 49.49 | gold quality |
| skin of leg | UBERON:0001511 | 48.30 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.64 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.